SLA 0.00% $3.34 silk laser australia limited

starting proposition

  1. 2,649 Posts.
    lightbulb Created with Sketch. 249
    Doesn't it seem many of the posts are based almost entirely on the starting proposition that the product actually works all of its wonders, and that sales will provide the evidence (as indeed it would) and so the quality or extent of clinical data is not considered relevant?

    This is a curious, barracking kind of outlook, when with a bio speccie, the data proving efficacy is usually considered the absolutely core basis for belief in the wisdom or otherwise of an investment.

    Sales can reasonably be expected to flow if something really works. In this case, that most crucial element seems to have remained quite opaque, if not largely unavailable for proper scrutiny.

    Leaving aside the increased production said to be available when the new factory commences, the company said on BRR months ago that they have already produced commercial quantities.

    If that hasn't been sold, and the company now asks for capital support at a price more than the share price - and over three years - doesn't that raise serious concerns?

    The other odd thing is to try to appreciate the attraction of paying 30 cents spread over three years for something you could buy (if you wanted to in the first place) for about 24 cents today - or why they would need the infusion of funds over such an extended period - given the optomistic demand/supply graphs put up to provide a sense that they are tantamount to sales forecasts. ( I haven't looked back at them tonight, but I think that's what they were.)

    Having recently ridden a nasty ride down on a speccie miner which rose and seriously fell, the lesson for me was that a large loss can quite easily become an even larger loss and getting out while the getting out is still possible is something to seriously consider.

    I expect many still holding feel or perhaps "hope" would be more accurate, that there is life in it yet, and maybe in a less hostile environment that would be true. But the cash position versus the sales/revenue position seen against the current market capitalisation appears at odds with that being a rational outlook.

    I don't post to annoy suffering holders, but I keep following this story, and all the self-styled "believers" posts, and wonder if holders get any sense that this really seems to be getting quite near the brink of calamity? Even if they pull a rabbit out of the hat, will it be a live rabbit?

 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.